Literature DB >> 17961176

Insulin sensitivity assessment with euglycemic insulin clamp in adult beta-thalassaemia major patients.

Apostolos Tsapas1, Efthymia Vlachaki, Athanasios Christoforidis, Maria Sarigianni, Eleni Bekiari, Vassilis Perifanis, Vassilis Tsapas, Konstantinos Paletas, Miranda Athanassiou-Metaxa.   

Abstract

OBJECTIVE: To assess insulin sensitivity in young adult normoglycemic beta-thalassaemia major patients.
METHODS: We measured insulin sensitivity with the euglycemic insulin clamp in 10 young adult (mean age 24.85 +/- 2.45 yrs) normoglycemic beta-thalassaemia major patients and 10 sex- & age-matched controls. Liver iron accumulation was assessed by magnetic resonance imaging (MRI).
RESULTS: Glucose infusion rate (M) required to maintain euglycemia was significantly reduced in thalassaemic patients compared to controls (261.5 +/- 63.5 mg/m2 x min vs. 355.6 +/- 35.3 mg/m2 x min, P = 0.008). Consequently, significantly reduced in the thalassaemic group were also tissue sensitivity to insulin (M/I(s-s)) and glucose metabolic clearance rate (M/G(s-s)). There was significant negative correlation between ferritin levels and glucose infusion rate (r = -0.918 P = 0.004). No significant correlations were observed between age, body mass index, daily transfusional iron accumulation, liver iron content and any of the euglycemic clamp parameters. Fasting insulin levels were significantly increased in patients with beta-thalassaemia major compared to controls (P = 0.01), and had significant negative correlation to MRI-derived liver iron content (r = -0.733, P = 0.03).
CONCLUSIONS: Our data indicate that reduced insulin sensitivity resulting in hyperinsulinaemia precedes the manifestation of glucose intolerance in patients with beta-thalassaemia major. Insulin resistance seems to correlate with increased serum ferritin levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961176     DOI: 10.1111/j.1600-0609.2007.00966.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  3 in total

1.  Prevalence of growth hormone deficiency in adult polytransfused β-thalassemia patients and correlation with transfusional and chelation parameters.

Authors:  M Poggi; C Pascucci; S Monti; P Pugliese; C Lauri; G Amodeo; G Girelli; V Toscano
Journal:  J Endocrinol Invest       Date:  2010-02-15       Impact factor: 4.256

2.  Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.

Authors:  Venée N Tubman; Ellen B Fung; Maria Vogiatzi; Alexis A Thompson; Zora R Rogers; Ellis J Neufeld; Janet L Kwiatkowski
Journal:  J Pediatr Hematol Oncol       Date:  2015-04       Impact factor: 1.289

3.  Zinc status affects glucose homeostasis and insulin secretion in patients with thalassemia.

Authors:  Ellen B Fung; Ginny Gildengorin; Siddhant Talwar; Leah Hagar; Ashutosh Lal
Journal:  Nutrients       Date:  2015-06-02       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.